Alzheimer's Biomarker Ethics

Investigate the development of blood-based biomarkers for neurodegenerative diseases: the science behind detection, how such tests might influence screening programs, clinical decision-making, patient privacy, and healthcare system design. Compare potential benefits with risks (diagnostic anxiety, false positives/negatives, equity), and propose a framework for responsible, equitable implementation that preserves informed consent and data protection while enabling scientific progress.